United States· US:66658-234_d1acb9d5-9241-4aeb-b3e7-f05dbc8c15a2
Kineret
A anakinra product containing anakinra, registered in United States by Swedish Orphan Biovitrum AB (publ). The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Anakinra is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AC03 (anakinra), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Anakinra · ATC L04AC03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ANAKINRA
- Manufacturer
- Swedish Orphan Biovitrum AB (publ)
- Country
- United States (US)
- ATC code
- L04AC03
- ATC class
- Anakinra
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1166658-234-07
- ndc1166658-234-28
- ndc1166658234077 SYRINGE, GLASS in 1 CARTON (66658-234-07) / .67 mL in 1 SYRINGE, GLASS
- ndc1166658234284 CARTON in 1 CASE (66658-234-28) / 7 SYRINGE, GLASS in 1 CARTON / .67 mL in 1 SYRINGE, GLASS
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
375 interactions on record for anakinra.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Anakinra · interactions on record
375 records
- 31 severe
- 337 moderate
- 7 minor
Most severe, free to view
- CladribineL01BB04severe
- PrednisoloneA07EA01moderate
- HydrocortisoneA07EA02moderate
- PrednisoneA07EA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Anakinra in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceKINERET 100 mg/0,67 mL, solution injectable en seringue préremplieSWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE)
- IrelandKineret 100 mg/0.67 ml solution for injection in pre-filled syringeSwedish Orphan Biovitrum AB
- NetherlandsKineret 100 mg/0,67 ml/ (150 mg/ml), oplossing voor injectieAmgen Europe B.V.
- CzechiaKINERETSwedish Orphan Biovitrum AB (publ), Stockholm
- BelgiumKineret 100 mgSwedish Orphan Biovitrum (Publ)
- SwedenKineret 100 mg Injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- SpainKINERET 100 mg/0,67 ml solucion inyectable en jeringa precargadaSwedish Orphan Biovitrum Ab (Publ)
- FinlandKineretSwedish Orphan Biovitrum AB (publ)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kineret
- Liechtenstein · Kineret
- Norway · Kineret
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0424e919-ebbf-45bc-851d-b55bb64d4ac6 GET /v1/drugs/0424e919-ebbf-45bc-851d-b55bb64d4ac6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "100",
"substance": "ANAKINRA",
"productndc": "66658-234",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/.67mL",
"application_number": "BLA103950",
"marketing_category": "BLA"
}See everything about anakinra.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.